MedTrace Logo

A Longitudinal Analysis of Biomarkers in Patients With ALS

NCT05309408 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2023-09-22

No results posted yet for this study

Summary

Longitudinally collect biomarkers from patients with amyotrophic lateral sclerosis (ALS) and control participants in order to further elucidate both potential causes and treatments for ALS. Samples and clinical information will be collected from patients with ALS and controls.

Conditions

Interventions

DIAGNOSTIC_TEST

Venipuncture

Venipuncture

DIAGNOSTIC_TEST

Lumbar Puncture

Lumbar Puncture

Sponsors & Collaborators

  • Massachusetts General Hospital

    collaborator OTHER

  • Holy Cross Hospital, Florida

    lead OTHER

Principal Investigators

  • Wilson Burke · Director

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-06-11
Primary Completion
2024-09-30
Completion
2024-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05309408 on ClinicalTrials.gov